Firefly Neuroscience (NASDAQ:AIFF) Major Shareholder Sells $46,132.80 in Stock

Firefly Neuroscience, Inc. (NASDAQ:AIFF) major shareholder Windsor Private Capital Lp sold 19,222 shares of the stock in a transaction that occurred on Tuesday, October 21st. The shares were sold at an average price of $2.40, for a total transaction of $46,132.80. Following the sale, the insider directly owned 1,314,804 shares of the company’s stock, valued at $3,155,529.60. The trade was a 1.44% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Windsor Private Capital Lp also recently made the following trade(s):

• On Wednesday, October 22nd, Windsor Private Capital Lp sold 78,031 shares of Firefly Neuroscience stock. The shares were sold at an average price of $2.07, for a total transaction of $161,524.17.
• On Monday, October 20th, Windsor Private Capital Lp sold 33,500 shares of Firefly Neuroscience stock. The shares were sold at an average price of $2.46, for a total transaction of $82,410.00.
• On Friday, October 17th, Windsor Private Capital Lp sold 45,036 shares of Firefly Neuroscience stock. The shares were sold at an average price of $2.55, for a total transaction of $114,841.80.
• On Thursday, October 16th, Windsor Private Capital Lp sold 40,139 shares of Firefly Neuroscience stock. The shares were sold at an average price of $2.65, for a total transaction of $106,368.35.
• On Wednesday, October 15th, Windsor Private Capital Lp sold 17,500 shares of Firefly Neuroscience stock. The shares were sold at an average price of $2.74, for a total transaction of $47,950.00.
• On Tuesday, October 14th, Windsor Private Capital Lp sold 29,500 shares of Firefly Neuroscience stock. The shares were sold at an average price of $2.74, for a total transaction of $80,830.00.
• On Monday, October 13th, Windsor Private Capital Lp sold 32,136 shares of Firefly Neuroscience stock. The shares were sold at an average price of $2.65, for a total transaction of $85,160.40.
• On Friday, October 10th, Windsor Private Capital Lp sold 74,810 shares of Firefly Neuroscience stock. The shares were sold at an average price of $2.70, for a total transaction of $201,987.00.
• On Thursday, October 9th, Windsor Private Capital Lp sold 30,126 shares of Firefly Neuroscience stock. The shares were sold at an average price of $2.94, for a total transaction of $88,570.44.

Firefly Neuroscience Trading Up 1.5%

Shares of Firefly Neuroscience stock opened at $2.08 on Friday. The firm has a market capitalization of $27.98 million, a price-to-earnings ratio of -0.83 and a beta of 2.11. Firefly Neuroscience, Inc. has a 12-month low of $1.86 and a 12-month high of $17.20. The firm’s 50 day simple moving average is $2.72 and its two-hundred day simple moving average is $2.94.

Firefly Neuroscience (NASDAQ:AIFF) last issued its earnings results on Wednesday, August 13th. The company reported ($0.14) earnings per share (EPS) for the quarter. Firefly Neuroscience had a negative return on equity of 464.02% and a negative net margin of 5,335.75%.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Firefly Neuroscience in a report on Friday. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Sell”.

Institutional Trading of Firefly Neuroscience

An institutional investor recently raised its position in Firefly Neuroscience stock. Geode Capital Management LLC boosted its position in shares of Firefly Neuroscience, Inc. (NASDAQ:AIFF) by 92.9% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 120,604 shares of the company’s stock after buying an additional 58,067 shares during the quarter. Geode Capital Management LLC owned approximately 0.94% of Firefly Neuroscience worth $341,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 4.96% of the company’s stock.

Firefly Neuroscience Company Profile

Firefly Neuroscience, Inc, a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.